NCT03442322

Brief Summary

Of the 1.4 million nursing home (NH) residents in long term care facilities, more than half have Alzheimer's disease or dementia. Due to changes in their familiar daily routines, difficulty expressing their thoughts or asking for what they need, and overstimulation (such as noise) or under stimulation (such as lack of activity), individuals with dementia often display disruptive behaviors like resisting help or continually repeating the same phrases. Medications are often prescribed to reduce agitation and aggressive behavior; however, these medications may not be effective and can have a negative impact on the individual. Therefore, families and other stakeholders strongly advocate the use of other types of approaches that focus on minimizing the cause of the behavior. Two facility-based methodologies include the transdisciplinary approach for integrated dementia care, which combines the expertise of all NH staff, who work together to build a common language and approach for each resident, and the multidisciplinary approach for problem-based dementia care, in which each staff member conducts individual assessments and makes discipline-specific recommendations. While prior research suggests that both of these facility-based approaches are useful, the circumstances under which each approach is most effective are not clear. This project will prospectively randomize 80 nursing homes to one of the two treatment arms to compare the effect of the transdisciplinary approach versus the multidisciplinary approach. This study will examine the difference between the two comparators with respect to facility rates of medications dispensed to residents with dementia, leading to enhanced quality of life for the resident. This project is important because it will address a key clinical dilemma NH staff face as they strive to optimize the use of alternative approaches to reduce disruptive behaviors in residents with dementia. Transforming the quality of dementia care in NHs and enhancing the quality of life of residents with dementia are high priorities for families and other advocates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable alzheimer-disease

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable alzheimer-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 22, 2018

Completed
21 days until next milestone

Study Start

First participant enrolled

March 15, 2018

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 26, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2022

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

August 19, 2024

Completed
Last Updated

August 19, 2024

Status Verified

March 1, 2024

Enrollment Period

4.4 years

First QC Date

January 31, 2018

Results QC Date

June 30, 2023

Last Update Submit

March 12, 2024

Conditions

Keywords

long term care residentsnursing home care

Outcome Measures

Primary Outcomes (12)

  • Dispensing of Psychotropic Medications

    Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 1-6 of Intervention.

    6-month period (months 1-6)

  • Dispensing of Psychotropic Medications

    Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 7-12 of Intervention.

    12-month period (months 7-12)

  • Dispensing of Psychotropic Medications

    Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 13-18 of Intervention.

    18-month period (months 13-18)

  • Behavioral Symptoms

    Percentage of nursing home residents with dementia who had behavioral symptoms over Months 1-6 of Intervention.

    6-month period (months 1-6)

  • Behavioral Symptoms

    Percentage of nursing home residents with dementia who had behavioral symptoms over Months 7-12 of Intervention.

    12-month period (months 7-12)

  • Behavioral Symptoms

    Percentage of nursing home residents with dementia who had behavioral symptoms over Months 13-18 of Intervention.

    18-month period (months 13-18)

  • Wandering

    Percentage of nursing home residents with dementia who had wandering over Months 1-6 of Intervention.

    6-month period (months 1-6)

  • Wandering

    Percentage of nursing home residents with dementia who had wandering over Months 7-12 of Intervention.

    12-month period (months 7-12)

  • Wandering

    Percentage of nursing home residents with dementia who had wandering over Months 13-18 of Intervention.

    18-month period (months 13-18)

  • Rejection of Care

    Percentage of nursing home residents with dementia who had rejection of care over Months 1-6 of Intervention.

    6-month period (months 1-6)

  • Rejection of Care

    Percentage of nursing home residents with dementia who had rejection of care over Months 7-12 of Intervention.

    12-month period (months 7-12)

  • Rejection of Care

    Percentage of nursing home residents with dementia who had rejection of care over Months 13-18 of Intervention.

    18-month period (months 13-18)

Secondary Outcomes (12)

  • Unintended Weight Loss

    6-month period (months 1-6)

  • Unintended Weight Loss

    12-month period (months 7-12)

  • Unintended Weight Loss

    18-month period (months 13-18)

  • Falls

    6-month period (months 1-6)

  • Falls

    12-month period (months 7-12)

  • +7 more secondary outcomes

Study Arms (2)

transdisciplinary approach

ACTIVE COMPARATOR

The transdisciplinary approach that is integrated across disciplines and provides core training for all providers, staff members, and stakeholders, using a common language to address care concerns and support continuity and sustainability

Other: transdisciplinary approach

multidisciplinary approach

ACTIVE COMPARATOR

The multidisciplinary approach that is problem-based and draws on the expertise of individual healthcare providers (e.g., occupational therapy) to address care concerns.

Other: multidisciplinary approach

Interventions

This approach is integrated across disciplines and provides core training for all providers, staff members, and stakeholders, using a common language to address care concerns and support continuity and sustainability;

transdisciplinary approach

This is a problem-based approach that draws on the expertise of individual healthcare providers (e.g., occupational therapy) to address care concerns.

multidisciplinary approach

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible nursing home facilities will
  • lack any existing dementia program targeting reduction of off-label psychotropic medication use
  • each serve \>60 long-term care residents with Alzheimer's or dementia
  • meet Center for Medicare \& Medicaid Services' minimum requirements for NHs (e.g., meeting the mandated number of hours of staff training on dementia care, performing regularly scheduled resident assessments).

You may not qualify if:

  • Facilities will be excluded if they have
  • less than 60 long-stay residents
  • an existing formal dementia care program in place
  • an off-label psychotropic medication reduction program
  • is located in a state that requires more than the Center for Medicare \& Medicaid Services' minimum for staff training requirements on the topic of dementia care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

Related Publications (1)

  • Piersol CV, Martinez J, Chew F, Perry B, Leland NE. Understanding the Experiences of Family Caregivers of Nursing Home Residents With Dementia: A Grounded Theory Study. Gerontologist. 2024 Apr 1;64(4):gnad102. doi: 10.1093/geront/gnad102.

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Limitations and Caveats

We were only able to assess post-training outcomes for 6 months prior to COVID-19 and it is possible that nursing homes would have achieved different outcomes after this initial start-up period. Similarly, the comparative effectiveness of the care approaches in 12- and 18-month follow-up period were confounded by the effects of COVID-19. Finally, the use of antipsychotic medication outcome was collected with a 7-day look back period, which may have resulted in underreporting.

Results Point of Contact

Title
Natalie Leland
Organization
University of Pittsburgh

Study Officials

  • Natalie E Leland, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Outcome assessors will be blinded to the treatment arm the facility is randomly assigned to.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: This cluster pragmatic trial randomized eligible nursing homes to one of the two intervention arms according to the predetermined protocol to evaluate the effect of the facility-level intervention on resident (i.e. long term care residents living with Alzheimer's Disease or Related Dementia) and staff outcomes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 31, 2018

First Posted

February 22, 2018

Study Start

March 15, 2018

Primary Completion

July 26, 2022

Study Completion

July 26, 2022

Last Updated

August 19, 2024

Results First Posted

August 19, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations